4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. 4d Pharma Plc - ADR market cap is $37.19M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. 4d Pharma Plc - ADR 52 week high is $10.84 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 4d Pharma Plc - ADR 52 week low is $1.50 as of November 20, 2026.
4d Pharma Plc - ADR stock price today is $1.65.
4d Pharma Plc - ADR stock price yesterday was $1.61.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. 4d Pharma Plc - ADR's P/E ratio is -0.43.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. 4d Pharma Plc - ADR P/B ratio is 1.1835.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. 4d Pharma Plc - ADR 50-day moving average is $2.90.